Search

everythinglearnresearchcommunity

for

Search:↓

PRP injections may improve hair thickness and density in female hair loss patients.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

The document concludes that finasteride can reduce nandrolone detection in doping tests, suggesting frequent testing and setting metabolite level thresholds for detection.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Tiny particles from stem cells help activate hair growth cells and encourage hair growth in mice without being toxic.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Follicular Unit Transplantation is a precise hair restoration technique that requires careful planning and a skilled team, and Follicular Unit Extraction offers a less invasive option.

Steroid hormones are crucial for body functions and have various medical uses, but their misuse can lead to dependence.

Ultrasound boosts finasteride's hair growth effects in mice.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

The document concludes that low-dose acne treatment is most suitable for moderate acne, with high patient satisfaction and low relapse rates.

The document concludes that different types of hair loss have specific treatments, and early diagnosis is crucial for preventing permanent hair loss.

Leonuri Herba alkaloids may help treat hormone-induced enlarged prostate in rats.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.